LPI (LP Information)' newest research report, the “Chronic Heart Failure (CHF) Devices Industry Forecast” looks at past sales and reviews total world Chronic Heart Failure (CHF) Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Chronic Heart Failure (CHF) Devices sales for 2023 through 2029. With Chronic Heart Failure (CHF) Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Heart Failure (CHF) Devices industry.
This Insight Report provides a comprehensive analysis of the global Chronic Heart Failure (CHF) Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Heart Failure (CHF) Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Chronic Heart Failure (CHF) Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Heart Failure (CHF) Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Heart Failure (CHF) Devices.
The global Chronic Heart Failure (CHF) Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chronic Heart Failure (CHF) Devices players cover Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Biovail Corporation and Abiomed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Heart Failure (CHF) Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps
Segmentation by application
Hospital
Clinic
Household
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott
Johnson & Johnson
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Biovail Corporation
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chronic Heart Failure (CHF) Devices market?
What factors are driving Chronic Heart Failure (CHF) Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Heart Failure (CHF) Devices market opportunities vary by end market size?
How does Chronic Heart Failure (CHF) Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Chronic Heart Failure (CHF) Devices by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Chronic Heart Failure (CHF) Devices by Country/Region, 2018, 2022 & 2029 2.2 Chronic Heart Failure (CHF) Devices Segment by Type 2.2.1 Implantable Left Ventricular Assist Device (LVAD) 2.2.2 Biventricular Pacemaker 2.2.3 Implantable Cardioverter-defibrillators (ICDs) 2.2.4 Continuous Positive Air Pressure Device (CPAP) 2.2.5 Bi-level Positive Air Pressure Device (BiPAP) 2.2.6 Heart Pumps 2.3 Chronic Heart Failure (CHF) Devices Sales by Type 2.3.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023) 2.3.2 Global Chronic Heart Failure (CHF) Devices Revenue and Market Share by Type (2018-2023) 2.3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2018-2023) 2.4 Chronic Heart Failure (CHF) Devices Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Household 2.4.4 Others 2.5 Chronic Heart Failure (CHF) Devices Sales by Application 2.5.1 Global Chronic Heart Failure (CHF) Devices Sale Market Share by Application (2018-2023) 2.5.2 Global Chronic Heart Failure (CHF) Devices Revenue and Market Share by Application (2018-2023) 2.5.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Application (2018-2023) 3 Global Chronic Heart Failure (CHF) Devices by Company 3.1 Global Chronic Heart Failure (CHF) Devices Breakdown Data by Company 3.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Company (2018-2023) 3.1.2 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company (2018-2023) 3.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Company (2018-2023) 3.2.1 Global Chronic Heart Failure (CHF) Devices Revenue by Company (2018-2023) 3.2.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2018-2023) 3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Company 3.4 Key Manufacturers Chronic Heart Failure (CHF) Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Chronic Heart Failure (CHF) Devices Product Location Distribution 3.4.2 Players Chronic Heart Failure (CHF) Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Chronic Heart Failure (CHF) Devices by Geographic Region 4.1 World Historic Chronic Heart Failure (CHF) Devices Market Size by Geographic Region (2018-2023) 4.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Chronic Heart Failure (CHF) Devices Market Size by Country/Region (2018-2023) 4.2.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Country/Region (2018-2023) 4.2.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Country/Region (2018-2023) 4.3 Americas Chronic Heart Failure (CHF) Devices Sales Growth 4.4 APAC Chronic Heart Failure (CHF) Devices Sales Growth 4.5 Europe Chronic Heart Failure (CHF) Devices Sales Growth 4.6 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Growth 5 Americas 5.1 Americas Chronic Heart Failure (CHF) Devices Sales by Country 5.1.1 Americas Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) 5.1.2 Americas Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) 5.2 Americas Chronic Heart Failure (CHF) Devices Sales by Type 5.3 Americas Chronic Heart Failure (CHF) Devices Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Chronic Heart Failure (CHF) Devices Sales by Region 6.1.1 APAC Chronic Heart Failure (CHF) Devices Sales by Region (2018-2023) 6.1.2 APAC Chronic Heart Failure (CHF) Devices Revenue by Region (2018-2023) 6.2 APAC Chronic Heart Failure (CHF) Devices Sales by Type 6.3 APAC Chronic Heart Failure (CHF) Devices Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Chronic Heart Failure (CHF) Devices by Country 7.1.1 Europe Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) 7.1.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) 7.2 Europe Chronic Heart Failure (CHF) Devices Sales by Type 7.3 Europe Chronic Heart Failure (CHF) Devices Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Chronic Heart Failure (CHF) Devices by Country 8.1.1 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) 8.1.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) 8.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Type 8.3 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Chronic Heart Failure (CHF) Devices 10.3 Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices 10.4 Industry Chain Structure of Chronic Heart Failure (CHF) Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Chronic Heart Failure (CHF) Devices Distributors 11.3 Chronic Heart Failure (CHF) Devices Customer 12 World Forecast Review for Chronic Heart Failure (CHF) Devices by Geographic Region 12.1 Global Chronic Heart Failure (CHF) Devices Market Size Forecast by Region 12.1.1 Global Chronic Heart Failure (CHF) Devices Forecast by Region (2024-2029) 12.1.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Chronic Heart Failure (CHF) Devices Forecast by Type 12.7 Global Chronic Heart Failure (CHF) Devices Forecast by Application 13 Key Players Analysis 13.1 Medtronic 13.1.1 Medtronic Company Information 13.1.2 Medtronic Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Medtronic Main Business Overview 13.1.5 Medtronic Latest Developments 13.2 Abbott 13.2.1 Abbott Company Information 13.2.2 Abbott Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Abbott Main Business Overview 13.2.5 Abbott Latest Developments 13.3 Johnson & Johnson 13.3.1 Johnson & Johnson Company Information 13.3.2 Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Johnson & Johnson Main Business Overview 13.3.5 Johnson & Johnson Latest Developments 13.4 Stanley Pharmaceuticals 13.4.1 Stanley Pharmaceuticals Company Information 13.4.2 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Stanley Pharmaceuticals Main Business Overview 13.4.5 Stanley Pharmaceuticals Latest Developments 13.5 New Haven Pharmaceuticals, Inc. 13.5.1 New Haven Pharmaceuticals, Inc. Company Information 13.5.2 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 New Haven Pharmaceuticals, Inc. Main Business Overview 13.5.5 New Haven Pharmaceuticals, Inc. Latest Developments 13.6 Boston Scientific Corporation 13.6.1 Boston Scientific Corporation Company Information 13.6.2 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Boston Scientific Corporation Main Business Overview 13.6.5 Boston Scientific Corporation Latest Developments 13.7 HeartWare 13.7.1 HeartWare Company Information 13.7.2 HeartWare Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.7.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 HeartWare Main Business Overview 13.7.5 HeartWare Latest Developments 13.8 Biovail Corporation 13.8.1 Biovail Corporation Company Information 13.8.2 Biovail Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Biovail Corporation Main Business Overview 13.8.5 Biovail Corporation Latest Developments 13.9 Abiomed 13.9.1 Abiomed Company Information 13.9.2 Abiomed Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Abiomed Main Business Overview 13.9.5 Abiomed Latest Developments 13.10 Symplmed Pharmaceuticals 13.10.1 Symplmed Pharmaceuticals Company Information 13.10.2 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Symplmed Pharmaceuticals Main Business Overview 13.10.5 Symplmed Pharmaceuticals Latest Developments 13.11 Berlin Heart GmbH 13.11.1 Berlin Heart GmbH Company Information 13.11.2 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Berlin Heart GmbH Main Business Overview 13.11.5 Berlin Heart GmbH Latest Developments 13.12 ReliantHeart, Inc. 13.12.1 ReliantHeart, Inc. Company Information 13.12.2 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 ReliantHeart, Inc. Main Business Overview 13.12.5 ReliantHeart, Inc. Latest Developments 13.13 Cardiokinetix 13.13.1 Cardiokinetix Company Information 13.13.2 Cardiokinetix Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Cardiokinetix Main Business Overview 13.13.5 Cardiokinetix Latest Developments 13.14 Biotronik 13.14.1 Biotronik Company Information 13.14.2 Biotronik Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Biotronik Main Business Overview 13.14.5 Biotronik Latest Developments 13.15 Jarvik Heart 13.15.1 Jarvik Heart Company Information 13.15.2 Jarvik Heart Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications 13.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Jarvik Heart Main Business Overview 13.15.5 Jarvik Heart Latest Developments 14 Research Findings and Conclusion